Compare SPRY & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | LGIH |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 829.3M | 984.3M |
| IPO Year | 2020 | 2013 |
| Metric | SPRY | LGIH |
|---|---|---|
| Price | $8.72 | $41.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | $40.00 | ★ $75.90 |
| AVG Volume (30 Days) | ★ 959.2K | 393.6K |
| Earning Date | 06-12-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $84,278,000.00 | ★ $1,705,504,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $91.00 | $14.33 |
| P/E Ratio | ★ N/A | $13.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.66 | $39.70 |
| 52 Week High | $18.63 | $74.84 |
| Indicator | SPRY | LGIH |
|---|---|---|
| Relative Strength Index (RSI) | 41.71 | 28.72 |
| Support Level | $8.61 | $41.82 |
| Resistance Level | $10.44 | $55.90 |
| Average True Range (ATR) | 0.46 | 1.88 |
| MACD | -0.02 | -1.00 |
| Stochastic Oscillator | 40.74 | 16.85 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.